Model Medicines launches oncology programs targeting AXL and BRD4

Press
Written By Lani Nguyen

Model Medicines Inc. has launched oncology programs focused on the discovery and development of therapeutics against two...

This article originally appeared on Bioworld, read the full article here.

Lani Nguyen
Previous

Model Medicines to Present at Wells Fargo Private Biotech Symposium
Next

Model Medicines Announces Launch of Oncology Programs with Multiple AI-Discovered Compounds Demonstrating Drug-Like Activity for Two High Value, Difficult to Drug, Oncogenic and Epigenetic Targets